Deerfield Management JNJ Position
ExitedDeerfield Management exited their position in JOHNSON & JOHNSON (JNJ) in Q1 2024, after holding the stock for 2 quarters.
The position was first reported in Q4 2023 and has been tracked across 2 quarterly 13F filings.
2 other tracked funds also hold JNJ.
There is an upcoming Phase 3 readout for JNJ-90301900 (NBTXR3) in 75 days (Jun 30, 2026), making the timing of Deerfield's position particularly relevant.
Deerfield Management JNJ Position History
Frequently Asked Questions
Does Deerfield Management own JNJ?
No. Deerfield Management exited their position in JOHNSON & JOHNSON (JNJ) in Q1 2024. They previously held the stock for 2 quarters.
How many hedge funds own JNJ?
2 specialist biotech hedge funds currently hold JNJ, including Rock Springs Capital, Tang Capital Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deerfield Management first buy JNJ?
Deerfield Management's position in JNJ was first reported in Q4 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deerfield Management's JNJ position increasing or decreasing?
Deerfield Management completely exited their JNJ position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
JNJCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deerfield ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →